The Management of Blood Safety in the Presence of Uncertain Risk: A United Kingdom Perspective

Transfusion Medicine Reviews

Volumn 26, Issue 3, 2012, Pages 238-251

  Watkins, Nicholas A ^a,b,c,d   Dobra, Stephen ^a,b,c,d   Bennett, Peter ^a,b,c,d   Cairns, John ^a,b,c,d   Turner, Marc L ^a,b,c,d  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b Department of Health ^*  (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM CONTAMINATION; BLOOD; BLOOD BANK; BLOOD COMPONENT THERAPY; BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DONOR SELECTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MEDICAL DECISION MAKING; MEDICAL ETHICS; NUCLEIC ACID ANALYSIS; PRACTICE GUIDELINE; QUALITY CONTROL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; THROMBOCYTE; UNITED KINGDOM; VARIANT CREUTZFELDT JAKOB DISEASE;

BLOOD BANKS; BLOOD DONORS; BLOOD SAFETY; COST-BENEFIT ANALYSIS; GREAT BRITAIN; HUMANS; PROGRAM EVALUATION; RISK; RISK ASSESSMENT; UNCERTAINTY;

EID: 84862212459     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2011.09.003     Document Type: Article

References (21)

1. Seitz R., Heiden M., Nubling C.M., et al. The harmonization of the regulation of blood products: A European perspective. Vox Sang 2008, 94:267-276.
2. Murphy M.F., Stanworth S.J., Yazer M. Transfusion practice and safety: Current status and possibilities for improvement. Vox Sang 2011, 100:46-59.
3. Murphy W. Managing threats rather than risks in blood transfusion: Robust design for a complex system. Transfusion 2006, 46:2011-2013.
4. http://www.shotuk.org/home/.
5. Soldan K., Sinka K. Evaluation of the de-selection of men who have had sex with men from blood donation in England. Vox Sang 2003, 84:265-273.
6. Pidgeon N.F., Hood C., Jones D., et al. Risk perception risk-Analysis, perception and management. London R Soc 1992, 89-134.
7. Health Protection Network Communicating with the public about health risks 2008, Health Protection Scotland, Glasgow.
8. Bennett P., Norman P., Moore L., et al. Health locus of control and value for health in smokers and nonsmokers. Health Psychol 1997, 16:179-182.
9. Sjoberg L. Factors in risk perception. Risk Anal 2000, 20:1-11.
10. Klein H.G. How safe is blood, really?. Biologicals 2010, 38:100-104.
11. Epstein J.S. Alternative strategies in assuring blood safety: An overview. Biologicals 2010, 38:31-35.
12. Leach Bennett J, Blajchman MA, Delage G, et al, Proceedings of a consensus conference: Risk-based decision making for blood safety. Transfus Med Rev 2011;267-92.
13. Kelly M., Morgan A., Ellis S., et al. Evidence based public health: A review of the experience of the National Institute of Health and Clinical Excellence (NICE) of developing public health guidance in England. Soc Sci Med 2010, 71:1056-1062.
14. NICE NICE, Methods for the development of NICE public health guidance 2006, NICE, London.
15. Marshall D.A., Kleinman S.H., Wong J.B., et al. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang 2004, 86:28-40.
16. HM Treasury The Green Book: Appraisal and evaluation in central government 2003, TSO, London.
17. Health and Safety Executive Reducing risks, protecting people: The HSE's decision-making process 2001, HSE Books, London.
18. Hergon E., Moutel G., Duchange N., et al. Risk management in transfusion after the HIV blood contamination crisis in France: The impact of the precautionary principle. Transfus Med Rev 2005, 19:273-280.
19. Wilson K. A framework for applying the precautionary principle to transfusion safety. Transfus Med Rev 2011, 25:177-183.
20. Wilson K., Wilson M., Hebert P.C., Graham I. The application of the precautionary principle to the blood system: The Canadian blood system's vCJD donor deferral policy. Transfus Med Rev 2003, 17:89-94.
21. Dodd R.Y. Prions and precautions: Be careful for what you ask. Transfusion 2010, 50:956-958.